Sopharma AD (WSE:SPH)

Sopharma AD Income Statement

Financials in millions BGN. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	2,394	2,121	1,875	1,663	1,603	1,439
Other Revenue	20.63	18.57	13.53	8.5	8.04	7.31
Revenue	2,415	2,139	1,889	1,672	1,611	1,446
Revenue Growth (YoY)	22.32%	13.27%	13.00%	3.73%	11.43%	12.27%
Cost of Revenue	1,878	1,675	1,470	1,306	1,264	1,131
Gross Profit	536.85	464.42	418.52	365.37	346.96	315.22
Selling, General & Admin	348.38	306.58	251.19	215.55	221.99	213.25
Other Operating Expenses	22.24	20	18	11.76	7.3	11.84
Operating Expenses	438.72	388.14	325.22	279.51	285.48	271.87
Operating Income	98.12	76.28	93.31	85.86	61.48	43.35
Interest Expense	-16.83	-12.87	-10.98	-6.02	-10.79	-12.41
Interest & Investment Income	5.09	2.94	3.42	3.19	4.87	5.23
Earnings From Equity Investments	38.05	25.72	24.47	22.64	12.09	5.98
Currency Exchange Gain (Loss)	-5.76	-5.76	-1.39	-0.13	2.29	-7.41
Other Non Operating Income (Expenses)	2.41	2.41	-2.55	-3.19	-0.94	-0.76
EBT Excluding Unusual Items	121.08	88.72	106.28	102.35	69	33.98
Impairment of Goodwill	-	-	-	-9.6	-	-3.5
Gain (Loss) on Sale of Investments	0.1	0.1	0.95	-1.59	0.15	0.09
Gain (Loss) on Sale of Assets	1.33	1.33	4.53	1.95	38.01	0.41
Asset Writedown	-0.19	-0.42	-1.44	-8.46	-10.34	-2.32
Legal Settlements	-	-	-	-	-	0.17
Other Unusual Items	1.73	1.73	0.87	0.43	0.75	2.61
Pretax Income	124.06	91.46	111.2	85.08	97.57	31.44
Income Tax Expense	14.46	9.07	11.32	8.74	5.87	6.16
Earnings From Continuing Operations	109.6	82.4	99.87	76.33	91.7	25.28
Minority Interest in Earnings	-7.21	-4.55	-3.9	-5.21	-2.21	4.53
Net Income	102.39	77.85	95.98	71.12	89.5	29.81
Net Income to Common	102.39	77.85	95.98	71.12	89.5	29.81
Net Income Growth	31.95%	-18.89%	34.95%	-20.53%	200.27%	-65.74%
Shares Outstanding (Basic)	498	493	392	364	376	377
Shares Outstanding (Diluted)	500	494	415	375	376	377
Shares Change (YoY)	4.07%	19.22%	10.64%	-0.36%	-0.31%	-0.11%
EPS (Basic)	0.21	0.16	0.24	0.20	0.24	0.08
EPS (Diluted)	0.20	0.16	0.23	0.19	0.24	0.08
EPS Growth	25.89%	-31.87%	21.05%	-19.73%	199.61%	-65.70%
Free Cash Flow	-5.39	43.25	20.64	90.74	-96.31	-202.96
Free Cash Flow Per Share	-0.01	0.09	0.05	0.24	-0.26	-0.54
Dividend Per Share	0.027	0.052	0.330	0.200	-	-
Dividend Growth	-51.45%	-84.33%	65.00%	-	-	-
Gross Margin	22.23%	21.71%	22.16%	21.86%	21.53%	21.80%
Operating Margin	4.06%	3.56%	4.94%	5.14%	3.82%	3.00%
Profit Margin	4.24%	3.64%	5.08%	4.25%	5.55%	2.06%
Free Cash Flow Margin	-0.22%	2.02%	1.09%	5.43%	-5.98%	-14.04%
EBITDA	141.24	112.85	127.86	118.97	93.85	74.19
EBITDA Margin	5.85%	5.27%	6.77%	7.12%	5.82%	5.13%
D&A For EBITDA	43.12	36.57	34.56	33.11	32.37	30.84
EBIT	98.12	76.28	93.31	85.86	61.48	43.35
EBIT Margin	4.06%	3.56%	4.94%	5.14%	3.82%	3.00%
Effective Tax Rate	11.65%	9.91%	10.18%	10.28%	6.02%	19.60%
Advertising Expenses	-	1.98	2.27	22.06	27.41	28.5

Source: S&P Global Market Intelligence. Standard template. Financial Sources.